Xilinx Shares Decline After Light Forecast
Dylan McGrath, EETimes
4/28/2016 08:00 AM EDT
SAN FRANCISCO—Shares of programmable logic vendor Xilinx Inc. traded lower in after hours trading Wednesday (April 27) after the company reported quarterly results that beat consensus analysts’ expectations but forecast roughly flat sales for the current quarter.
Xilinx (San Jose, Calif.) said it expects sales for the current quarter, which closes in June, to be roughly flat with those it reported for the fourth quarter of its fiscal 2016, $571 million. The target fell short of Wall Street’s expectations, which called for Xilinx to post fiscal first quarter sales of about $579 million.
The $571 million in sales for the fiscal fourth quarter, which closed in March, came in up 1% compared with both the previous and year-ago quarters. The revenue figure beat consensus analysts’ expectations of about $566 million.
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Xilinx, Inc. Hot IP
Related News
- Global Silicon Wafer Shipment Growth to Bounce Back in 2024 After 2023 Decline, SEMI Reports
- After Record Sales in 2022, Semi Sales Forecast to Fall -5% in 2023
- Gartner Forecasts Worldwide Semiconductor Revenue Growth to Decline 3.6% in 2023
- 2023 Semi Capex Forecast Sees Largest Decline Since 2008-09
- Industry R&D Spending To Rise 9% After Hitting Record in 2021
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






